Assessment of Pexelizumab in Acute Myocardial Infarction - APEX AMI – Presented at AHA 2006

Description:

The goal of the trial was to evaluate the use of pexelizumab, an anti-C5 complement monoclonal antibody fragment, compared with placebo, among patients undergoing primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (MI).